StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BQST

BioQuest Corp.

BQST Pharmaceutical Preparations EDGAR ↗
$0.07
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$765K
Revenue (TTM)
$31.0K
Net income (TTM)
-$507K
EPS (TTM)
$-0.04
P/E ratio
Dividend yield
Free cash flow
Cash
$15.0K
Total assets
$15.0K
Gross margin
52-week range
$0.07 – $1.00

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2022-07-31 Sep 12, 2022 10-K Fiscal year ended 2022-04-30 Aug 15, 2022 10-Q Quarter ended 2022-01-31 May 27, 2022 8-K Changed accountants May 19, 2022 10-Q Quarter ended 2021-10-31 May 16, 2022 10-Q Quarter ended 2021-07-31 Apr 29, 2022 10-K Fiscal year ended 2021-04-30 Aug 13, 2021 10-Q Quarter ended 2021-01-31 Jun 15, 2021 10-Q Quarter ended 2020-10-31 Dec 14, 2020 8-K Change in control; Director or officer change; Item 5.06 Oct 14, 2020 8-K/A Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Change in control; Director or officer change; Item 5.06 May 27, 2015 8-K/A Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Change in control; Director or officer change; Item 5.06 Apr 29, 2015 10-Q Quarter ended 2015-01-31 Mar 17, 2015 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Director or officer change Mar 12, 2015 10-Q Quarter ended 2014-10-31 Dec 15, 2014 8-K/A Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Change in control; Director or officer change; Item 5.06 Dec 12, 2014 10-Q Quarter ended 2014-07-31 Sep 19, 2014 10-K/A Fiscal year ended 2014-04-30 Sep 10, 2014 8-K FORM 8-K Sep 2, 2014 10-K Fiscal year ended 2014-04-30 Aug 13, 2014 8-K Entered a material agreement Aug 6, 2014 8-K Changed accountants Jul 22, 2014 8-K Director or officer change Jul 9, 2014 8-K Amended charter or bylaws Jun 26, 2014 8-K Change in control; Director or officer change Apr 10, 2014 10-Q Quarter ended 2014-01-31 Mar 25, 2014 10-Q Quarter ended 2013-10-31 Dec 17, 2013 10-Q Quarter ended 2013-07-31 Oct 22, 2013
Other filings
253G2 Oct 8, 2024 1-U Item 1; Item 3 Aug 28, 2024 QUALIF Aug 21, 2024 CORRESP Aug 19, 2024 CORRESP Jul 30, 2024 1-A/A Jul 26, 2024 UPLOAD Jul 15, 2024 CORRESP Jul 1, 2024 1-A/A Jul 1, 2024 UPLOAD Jun 11, 2024 1-A May 15, 2024 1-Z Apr 17, 2024